HomeKNSAN • BMV
add
Kiniksa Pharmaceuticals Internationl PLC
Previous close
$734.19
Year range
$670.79 - $779.45
Market cap
3.41B USD
Avg Volume
94.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 202.13M | 64.95% |
Operating expense | 91.38M | 20.64% |
Net income | 14.20M | 259.75% |
Net profit margin | 7.02 | 196.83% |
Earnings per share | 0.17 | 241.67% |
EBITDA | 20.24M | 207.07% |
Effective tax rate | 38.98% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 414.07M | 69.96% |
Total assets | 763.63M | 31.54% |
Total liabilities | 196.03M | 37.93% |
Total equity | 567.61M | — |
Shares outstanding | 76.54M | — |
Price to book | 98.68 | — |
Return on assets | 6.70% | — |
Return on capital | 8.81% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 14.20M | 259.75% |
Cash from operations | 53.89M | 187.13% |
Cash from investing | -70.81M | -208.46% |
Cash from financing | 7.66M | 257.52% |
Net change in cash | -9.26M | -110.74% |
Free cash flow | 48.05M | 9,585.06% |
About
Founded
2015
Website
Employees
366
